Previous Close | 23.14 |
Open | 23.13 |
Bid | 21.76 x 800 |
Ask | 23.60 x 1000 |
Day's Range | 21.65 - 23.13 |
52 Week Range | 12.05 - 34.98 |
Volume | |
Avg. Volume | 497,317 |
Market Cap | 1.305B |
Beta (5Y Monthly) | 0.92 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
ALL-REMOTE COMPANY/WILMINGTON, Del., March 19, 2024--Phreesia, a leader in patient intake, outreach and activation, has named Jack Callahan as the company’s new Chief Technology Officer.
WILMINGTON, Del., March 14, 2024--Phreesia, Inc. (NYSE: PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2024.
WILMINGTON, Del., February 27, 2024--Phreesia announces that its Chief Clinical Officer Hilary Hatch, PhD, has been selected to participate in NQF's 2024-2025 Leadership Consortium.